Patrice High
Family Medicine · Lugoff, SCNPI 1649280231
Payments from drug & device makers
Across 148 payments — averaging $16.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$336
- Novo Nordisk$255
- Amgen$247
- Abbott$202
- Lilly USA, LLC$199
- Pfizer$123
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,444100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 20 | $336 |
| Novo Nordisk | 17 | $255 |
| Amgen | 14 | $247 |
| Abbott | 4 | $202 |
| Lilly USA, LLC | 14 | $199 |
| Pfizer | 8 | $123 |
| Boehringer Ingelheim | 7 | $106 |
| AbbVie(2 entities) | 7 | $103 |
| Daiichi Sankyo Inc. | 4 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $66 |
| Novartis | 4 | $66 |
| Bayer | 4 | $65 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $59 |
| Jazz Pharmaceuticals Inc. | 3 | $55 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $55 |
| Kowa Pharmaceuticals America, Inc. | 4 | $52 |
| Astellas Pharma US Inc | 3 | $51 |
| Merck | 4 | $47 |
| Vivus LLC | 3 | $45 |
| Exact Sciences | 2 | $30 |
| Dynavax Technologies Corporation | 2 | $30 |
| GSK | 2 | $29 |
| Amarin Pharma, Inc. | 2 | $22 |
| Adlon Therapeutics L.p. | 1 | $18 |
| Genentech USA, Inc. | 1 | $18 |
| Mannkind Corporation | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Ironwood Pharmaceuticals, Inc | 1 | $13 |
| Antares Pharma, Inc. | 1 | $13 |
| Acerus Pharmaceuticals Corporation | 1 | $12 |
| Johnson & Johnson | 1 | $11 |
| Gilead | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,444 in reported general payments places this provider in the 75th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 11 | $18,422 |
| JardianceEmpagliflozin | 16 | $13,957 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 13 | $2,520 |
| Atorvastatin Calcium | 60 | $648 |
| Omeprazole | 42 | $500 |
| Metoprolol Succinate | 33 | $487 |
| Fluticasone Propionate | 31 | $431 |
| Rosuvastatin Calcium | 39 | $420 |
| Potassium Chloride | 29 | $404 |
| Lisinopril | 40 | $311 |
| Pioglitazone Hcl | 12 | $300 |
| Amlodipine Besylate | 76 | $295 |
| Montelukast Sodium | 22 | $290 |
| Gabapentin | 18 | $264 |
| Valsartan | 16 | $236 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $255 | $18,42211 claims |
| Boehringer IngelheimJardiance | $106 | $13,95716 claims |
| GSKShingrix | $29 | $2,52013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Lugoff
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
- Edward NewtonCharleston$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.